Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma

Cancer Immunology, Immunotherapy

Volumn 62, Issue 9, 2013, Pages 1499-1509

  Vik Mo, Einar Osland ^a,b   Nyakas, Marta ^b   Mikkelsen, Birthe Viftrup ^a,b   Moe, Morten Carstens ^b   Due Tønnesen, Paulina ^b   Suso, Else Marit Inderberg ^b   Sæbøe Larssen, Stein ^b   Sandberg, Cecilie ^a,b   Brinchmann, Jan E ^b   Helseth, Eirik ^b   Rasmussen, Anne Marie ^b   Lote, Knut ^b   Aamdal, Steinar ^b   Gaudernack, Gustav ^b   Kvalheim, Gunnar ^b   Langmoen, Iver A ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Autologous cell culture; Brain cancer stem cell; Dendritic cell; Glioblastoma; Immunotherapy; Tumorsphere

Indexed keywords

CORTICOSTEROID; DENDRITIC CELL VACCINE; MESSENGER RNA; SURVIVIN; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; ALLERGIC ENCEPHALOMYELITIS; ANOREXIA; ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS CANCER STEM CELL; BRAIN EDEMA; CANCER GROWTH; CANCER IMMUNIZATION; CANCER MORTALITY; CANCER STEM CELL; CANCER SURVIVAL; CELL CULTURE; CELL EXPANSION; CELL SUSPENSION; CELL THERAPY; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENDRITIC CELL; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; FATIGUE; FEASIBILITY STUDY; FEMALE; FOCAL EPILEPSY; GENE AMPLIFICATION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; MONOCYTE; NAUSEA; OVERALL SURVIVAL; PAIN; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; RETINITIS; RNA ISOLATION; SEIZURE; T LYMPHOCYTE ACTIVATION; TUMOR VOLUME; UVEA DISEASE; UVEAL INFLAMMATION;

BRAIN NEOPLASMS; CANCER VACCINES; COMBINED MODALITY THERAPY; DENDRITIC CELLS; DISEASE-FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MALE; MIDDLE AGED; NEOPLASTIC STEM CELLS; RNA, MESSENGER; TELOMERASE; TRANSFECTION;

EID: 84883458285     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-013-1453-3     Document Type: Article

References (48)

1. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459-466
2. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105-111
3. Vermeulen L, de Sousa e Melo F, Richel DJ, Medema JP (2012) The developing cancer stem-cell model: clinical challenges and opportunities. Lancet Oncol 13:e83-e89
4. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA (2002) Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39:193-206
5. Reynolds BA, Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255:1707-1710
6. Chen R, Nishimura MC, Bumbaca SM, Kharbanda S, Forrest WF, Kasman IM, et al. (2010) A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 17:362-375
7. Deleyrolle LP, Ericksson G, Morrison BJ, Lopez JA, Burrage K, Burrage P, et al. (2011) Determination of somatic and cancer stem cell self-renewing symmetric division rate using sphere assays. PLoS ONE 6:e15844
8. Moe MC, Varghese M, Danilov AI, Westerlund U, Ramm-Pettersen J, Brundin L, et al. (2005) Multipotent progenitor cells from the adult human brain: neurophysiological differentiation to mature neurons. Brain 128:2189-2199
9. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64:7011-7021
10. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828
11. Varghese M, Olstorn H, Sandberg C, Vik-Mo EO, Noordhuis P, Nistér M, et al. (2008) A comparison between stem cells from the adult human brain and from brain tumors. Neurosurgery 63:1022-1033
12. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756-760
13. Salmaggi A, Boiardi A, Gelati M, Russo A, Calatozzolo C, Ciusani E, et al. (2006) Glioblastoma-derived tumorspheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 54:850-860
14. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ (2008) Efficient tumour formation by single human melanoma cells. Nature 456:593-598
15. Eppert K, Takenaka K, Lechman ER, Waldron L, Nilsson B, van Galen P, et al. (2011) Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 17:1086-1093
16. Gentles AJ, Plevritis SK, Majeti R, Alizadeh AA (2010) Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA 304:2706-2715
17. Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Dereqibus MC, et al. (2006) Isolation and characterization of a stem cell population from adult human liver. Stem Cells 24:2840-2850
18. Takamiya M, Haider KH, Ashraf M (2011) Identification and characterization of a novel multipotent sub-population of Sca-1(+) cardiac progenitor cells for myocardial regeneration. PLoS ONE 6:e25265
19. Wu Y, Wu PY (2009) CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev 18:1127-1134
20. Kyte JA, Mu L, Aamdal S, Kvalheim G, Dueland S, Hauser M, et al. (2006) Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA. Cancer Gene Ther 13:905-918
21. Mu LJ, Kyte JA, Kvalheim G, Aamdal S, Dueland S, Hauser M, et al. (2005) Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients. Br J Cancer 93:749-756
22. + cytolytic T cells. Cancer Res 69:8886-8893
23. Pellegatta S, Poliani PL, Corno D, Menghi F, Ghielmetti F, Suarez-Merino B, et al. (2006) Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res 66:10247-10252
24. Saeboe-Larssen S, Fossberg E, Gaudernack G (2002) mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT). J Immunol Methods 259:191-203
25. Suso EM, Dueland S, Rasmussen AM, Vetrhus T, Aamdal S, Kvalheim G, et al. (2011) hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes. Cancer Immunol Immunother 60:809-818
26. Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, Rønning P, et al. (2010) Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol Scand 122:159-167
27. Vik-Mo EO, Sandberg C, Olstorn H, Varghese M, Brandal P, Ramm-Pettersen J, et al. (2010) Brain tumor stem cells maintain overall phenotype and tumorigenicity after in vitro culturing in serum-free conditions. Neuro Oncol 12:1220-1230
28. Vik-Mo EO, Sandberg C, Joel M, Stangeland B, Watanabe Y, Mackay-Sim A, et al. (2011) A comparative study of the structural organization of spheres derived from the adult human subventricular zone and glioblastoma biopsies. Exp Cell Res 317:1049-1059
29. Boczkowski D, Nair SK, Nam JH, Lyerly HK, Gilboa E (2000) Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer Res 60:1028-1034
30. Kyte JA, Kvalheim G, Aamdal S, Saeboe-Larssen S, Gaudernack G (2005) Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination. Cancer Gene Ther 12:579-591
31. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent R, Ford R, et al. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228-247
32. Wakimoto H, Mohapatra G, Kanai R, Curry WT Jr, Yip S, Nitta M, et al. (2012) Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. Neuro Oncol 14:132-144
33. deCarvalho AC, Nelson K, Lemke N, Lehman NL, Arbab AS, Kalkanis S, et al. (2010) Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo. Stem Cells 28:181-190
34. Singh SK, Clarke ID, Hide T, Dirks PB (2004) Cancer stem cells in nervous system tumors. Oncogene 23:7267-7273
35. Laks DR, Masterman-Smith M, Visnyei K, Angenieux B, Orozco NM, Foran I, et al. (2009) Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cell 27:980-987
36. Pallini R, Ricci-Vitiani L, Banna GL, Signore M, Lombardi D, Todaro M, et al. (2008) Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res 14:8205-8212
37. + glioma cells: possible targets of immunotherapy. J Neurooncol 83:121-131
38. Cancer Research Genome Atlas Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068
39. - glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer Res 70:2030-2040
40. Johnson RS, Walker AI, Ward SJ (2009) Cancer vaccines: will we ever learn? Expert Rev Anticancer Ther 9:67-74
41. Iversen TZ, Brimnes MK, Nikolaisen K, Andersen RS, Hadrup SR, Andersen MH, et al. (2013) Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients. Oncoimmunology 2:e23288
42. Kyte JA, Gaudernack G, Dueland S, Trachsel S, Julsrud L, Aamdal S (2011) Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients. Clin Cancer Res 17:4568-4580
43. Ardon H, Van Gool S, Verschuere T, Maes W, Fieuws S, Sciot R, et al. (2012) Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial. Cancer Immunol Immunother 61:2033-2044
44. Grossman Z, Min B, Meier-Schellersheim M, Paul WE (2004) Concomitant regulation of T-cell activation and homeostasis. Nat Rev Immunol 4:387-395
45. Parajuli P, Mathupala S, Sloan AE (2004) Systematic comparison of dendritic cell-based immunotherapeutic strategies for malignant gliomas: in vitro induction of cytolytic and natural killer-like T cells. Neurosurgery 55:1194-1204
46. Moe MC, Kolberg RS, Sandberg C, Vik-Mo E, Olstorn H, Varghese M, et al. (2009) A comparison of epithelial and neural properties in progenitor cells derived from the adult human ciliary body and brain. Exp Eye Res 88:30-38
47. Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J, et al. (2009) Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens. Stem Cells 27:1734-1740
48. Puphanich S, Wheeler CJ, Rudnick J, Mazer M, Wang HQ, Nuno M, et al. (2013) Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma. Cancer Immunol Immunother 62:125-135